Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer

The authors found metabolic reprogramming that increased fatty acid β-oxidation in estrogen receptor-alpha positive breast cancers as a mechanism of resistance to endocrine therapy.